Surpass Streamline Flow-Diverter Embolization Device for Treatment of Iatrogenic and Traumatic Internal Carotid Artery Injuries

Ghorbani, Mohammad; Shojaei, Hamidreza; Bavand, Karan; Azar, Maziar

doi:10.3174/ajnr.a5607

Cited by 14 publications

(9 citation statements)

References 17 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The procedures were successful in all cases, and control angiographies revealed a complete occlusion of aneurysms in 9 (82%) patients [2]. Also, we had a positive experience with FDDs for treatment of traumatic and iatrogenic internal carotid artery injuries showing that flow diversion is effective in healing vessel wall damages [22].…”

Section: Discussionmentioning

confidence: 79%

Flow diverter embolization device for endovascular treatment of ruptured blister and wide necked very small aneurysms

Ghorbani

Griessenauer

Wipplinger

et al. 2019

Heliyon

Self Cite

View full text Add to dashboard Cite

PurposeRuptured blood blisters (BBA) and very small, wide necked aneurysms (VSA) remain challenging lesions to treat due to their small size, wide necks, and thin, fragile walls. In the present study, we reviewed our experience with these aneurysms treated by flow diversion.MethodsA total of 18 patients with hemorrhage due to a ruptured BBAs and VSAs, treated with flow diversion between July 2014 and March 2016 were included in this study. We analyzed clinical and radiographic outcomes.ResultsA total of 12 (66.7%) VSAs and 6 (33.3%) BBAs were treated with flow diversion. Fifteen (83.3%) and three (16.7%) aneurysms were located on the internal carotid artery and the basilar artery, respectively. On admission, a GCS score of 15 and WFNS grade 1 were found in 14 (77.7%) patients, 3 patients had an admission GCS of 13 and WFNS grade 2, one had an admission GCS of 8 and WFNS of 4. Fisher CT grades 2, 3, and 4 were observed in 11 (61.1%), 1 (5.6%), and 6 (33.3%) patients, respectively. Flow diversion was performed on average 5.6 days after onset of hemorrhage. 6 months post-intervention angiography showed complete obliteration of the aneurysms in all patients.ConclusionOur findings indicate that flow diversion in the acute and subacute phase of hemorrhage is a reliable treatment for reducing complications in patients with BBAs and VSAs. In patients with poor clinical presentation it might be reasonable to delay treatment until the first signs of recovery become apparent.

show abstract

Section: Discussionmentioning

confidence: 79%

Flow diverter embolization device for endovascular treatment of ruptured blister and wide necked very small aneurysms

Ghorbani

Griessenauer

Wipplinger

et al. 2019

Heliyon

Self Cite

View full text Add to dashboard Cite

show abstract

“…Conducting SE-FD clinical trials are delayed in comparison to previous FDs. SS-FD had already received FDA approval in 2018 and has several clinical trials including the surpass intracranial aneurysms embolization system pivotal trial (SCENT) [ 25 ] and systematic reviews to support its use [ 47 ]. Therefore, some researchers and clinicians may anticipate that the evidence to support SS-FD is sufficient to use the new SE-FD or its use might be based on anecdotal evidence.…”

Section: Discussionmentioning

confidence: 99%

Surpass Evolve Flow Diverter for the Treatment of Intracranial Aneurysm: A Systematic Review

et al. 2022

View full text Add to dashboard Cite

Purpose: This systematic review aims to summarize the evidence investigating the effectiveness and safety of the Surpass Evolve-Flow Diverter (SE-FD) to treat brain aneurysms. Method: We searched MEDLINE, EMBASE, CINAHL, Web of Science, and Cochrane Library from January 2019 to 29 March 2022. Terms related to the “intracranial aneurysm” and “surpass evolve flow diverter” concepts were used to search the databases; Medical Subject Headings (MeSH) and reference hand search were also utilized. Results: The searches primarily identified 1586 documents. A total of five studies (four case series and one cohort) were included in this review. In the included studies, 192 (74 male and 118 females) patients with 198 aneurysms were involved. In total, 153 SE-FDs were used to treat 145 aneurysms. Complete occlusion was achieved in 69/145 (48%) cases and near-complete occlusion in 24/145 (17%) cases from aneurysms treated with SE-FD. Reported postoperative complications included stent thrombosis (n = 4 patients), hemorrhage (n = 5 patients), ischemia (n = 9 patients), and neurological complications (n = 12 patients). In total, four deaths were reported with only one related to the SE-FD procedure. Conclusion: The results of this review are based on observational data, due to the absence of clinical trials. The findings of the included studies suggest that the effectiveness of the SE-FD procedure is lower than previous FDs but the safety is similar. The included studies also suggested that SE-FD has navigability and resistance to twisting, which makes the procedure an easier method to treat aneurysms that are proximal and distal to the circle of Willis deployment. This review highlights the urgency to conduct clinical trials to confirm these suggestions.

show abstract

“…The FDS is a self-expanding tubular mesh made of cobalt-chromium with more than 30% metal coverage and 3 times the vessel wall coverage compared with traditional intracranial stents [80]. The woven tubes can provide a significantly increased potential for thrombosis by diverting blood flow away from the aneurysm and reconstructing the diseased parent artery as well as providing a scaffold for endothelial healing [81].…”

Section: Flow-diverting Stent Deploymentmentioning

confidence: 99%

Endovascular treatment of blunt injury of the extracranial internal carotid artery: the prospect and dilemma

Wang¹,

Li²,

Piao³

et al. 2021

Int. J. Med. Sci.

View full text Add to dashboard Cite

Surpass Streamline Flow-Diverter Embolization Device for Treatment of Iatrogenic and Traumatic Internal Carotid Artery Injuries

Cited by 14 publications

References 17 publications

Flow diverter embolization device for endovascular treatment of ruptured blister and wide necked very small aneurysms

Flow diverter embolization device for endovascular treatment of ruptured blister and wide necked very small aneurysms

Surpass Evolve Flow Diverter for the Treatment of Intracranial Aneurysm: A Systematic Review

Endovascular treatment of blunt injury of the extracranial internal carotid artery: the prospect and dilemma

Contact Info

Product

Resources

About